Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201304059 Principal Investigator: Waqar, Saiama
Title: A Phase 2 Study of Neratinib and Neratinib Plus Temsirolimus in Patients with Non-Small Cell Lung Cancer Carrying Known HER2 Activating Mutations
Phase: II Disease Site: Lung
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this study is to find out whether or not neratinib alone or in combination with temsirolimus can help control lung cancer with a mutation called HER2.
 
More Information:
ClinicalTrials.Gov Site
Internal Protocol Documents (requires Siteman administrative database password)